Abstract
Subretinal neovascular membranes were observed in three patients with chronic membranoproliferative glomerulonephritis type II (dense deposit disease). The first signs of glomerulonephritis occurred at respective ages of 13, 10 and 10 years; subretinal neovascular membranes were noted at respective ages of 25, 32 and 32 years. All patients had bilateral, widespread retinal pigment epithelial abnormalities. Our findings indicate that subretinal neovascularization is a complication of dense deposit disease. In one patient, the early recognition and laser treatment of an extrafoveal subretinal neovascular membrane prevented further loss of vision.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Duvall-Young J, MacDonald M, McKechnie N (1989) Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol 73:297–302
Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W (1989) Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol 73:900–906
Ormos J, Magori A, Sonkodi S, Streitmann K (1979) Type II membranoproliferative glomerulonephritis with electron-dense basement membrane alteration in the spleen. Arch Pathol Lab Med 103:265–266
Raines MF, Duvall-Young J, Short CD (1989) Fundus changes in mesangiocapillary glomerulonephritis type 11: vitreous fluorophotometry. Br J Ophthalmol 73:907–910
Thorner P, Baumal R (1982) Extraglomerular dense deposits in dense deposit disease. Arch Pathol Lab Med 106:628–631
West CD, McAdams AJ (1983) Membranoproliferative glomerulonephritis. In: Massry SG, Glassock RS (eds) Textbook of nephrology. Williams and Wilkins, Baltimore, pp 6.46–6.52
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Leys, A., Michielsen, B., Leys, M. et al. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefe's Arch Clin Exp Ophthalmol 228, 499–504 (1990). https://doi.org/10.1007/BF00918479
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00918479